Connect with us


Materials science
Covestro renewed contract with Klaus Schäfer



Chemicals, Ingredients & Auxiliary Materials

The Supervisory Board of Covestro AG has extended the contract of Board of Management member Dr. Klaus Schäfer by five years until the end of 2022 on January 1, 2018. Schäfer has been a member of the Board of Management of Covestro AG since the going public in 2015. As Chief Technology Officer (CTO), he is responsible for production and technology as well as all chemical production sites of the company. Since mid-2017, he also acts as labor director.

With the early renewal of the contract, the company underlines its commitment to continuity just like it did with the appointment of the Board of Management member Dr Markus Steilemann as successor of CEO Patrick Thomas.

“We are pleased to continue the successful cooperation with Dr. Klaus Schäfer,” said Dr. Richard Pott, Chairman of the Supervisory Board of Covestro AG. “He made significant contributions to the success story of Covestro as an independent company. As a proven industry expert with long-term leadership experience in the company, he ensures that Covestro is able to convince the market with state-of-the-art production facilities and competitive technology. Furthermore, he is highly regarded and trusted among employees, not only as labor director.”

“I would like to thank the Supervisory Board for its trust and I am looking forward to successfully continuing Covestro’s history together with all the company’s employees and my colleagues at the Board of Management,” said Dr. Klaus Schäfer.

Schäfer is part of the three-member management team of Covestro with Chief Executive Officer (CEO) Patrick Thomas and Dr. Markus Steilemann, Chief Commercial Officer (CCO) and future CEO. From April 1, 2018 onwards, Dr. Thomas Toepfer will complement the Board of Management as Chief Financial Officer (CFO).

The contract of Klaus Schäfer would have expired at the end of August 2018. In accordance with the German Stock Corporation Act and the Rules of Procedure of the Supervisory Board of Covestro AG, the Supervisory Board generally decides on a contract extension of Board of Management members after the beginning of the last year of their current contract.

Chemicals News Processing Technologies

Fusion processes can be triggered by pulsed electric fields



Pulsed electric fields caused by lightning strikes make themselves felt as voltage spikes and represent a destructive hazard for electronic components. They cause considerable damage. A team from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has now discovered that such voltage spikes can have quite useful properties. In the journal Physical Review Research (DOI: 10.1103/PhysRevResearch.3.033153), the scientists report how, for example, nuclear fusion processes can be significantly enhanced by extremely strong and fast pulsed electric fields. Nuclear fusions, such as those that take place in the sun, are made possible by the quantum mechanical tunnel effect.

“One consequence of the tunnel effect is that similarly charged particles can overcome their mutual repulsion, even if their energy is not actually sufficient to do so – at least not according to the laws of classical mechanics. We can observe something like this, for example, in the fusion of two light atomic nuclei: The closer one nucleus approaches the other, the greater the repulsion, which we can imagine figuratively as a mountain piling up in front of the nucleus, the so-called potential barrier. Instead of taking the more energy-consuming path over the top, the laws of quantum mechanics allow the nucleus to penetrate or ‘tunnel’ straight through this mountain in a much more energetically favorable way – and finally to fuse.”

– Prof. Ralf Schützhold, Head of the Department of Theoretical Physics

Although the tunneling effect plays an important role in many areas of physics and was first described nearly one hundred years ago, our understanding of the process is still incomplete today. “Various facets of the influence of electric fields on tunneling processes were already known. For example, electric fields can additionally accelerate particles, helping them to gain more energy. They can also deform the potential barrier and increase the tunneling probability in this way,” says Dr. Christian Kohlfürst, outlining the situation at the beginning of their research.

His colleague Dr. Friedemann Queisser briefly sums up their results: “Our calculations now show for the first time a special feature of pulsed electric fields that change rapidly in time: they can ensure that the particles are pushed out of the potential barrier, figuratively speaking, and thus tunnel more easily.” The calculations of the HZDR team show this quite concretely in various examples, including a fusion reaction of interest for possible energy generation: the fusion of a proton with the isotope boron-11.

Fusion reaction with advantages

It is interesting primarily because of the relatively readily available fuel. Three alpha particles, each with a double positive charge, are produced in the process. What is remarkable about this reaction is that the energy is released in the form of charged particles and not as neutron radiation as in the most well-known fusion reactions at present. This has advantages: For one thing, the problems associated with neutron flux would be significantly reduced, such as the dangers of dealing with ionizing radiation. For another, the energy of charged particles can be converted directly, and thus much more easily, into electricity.

However, the conditions required to use the reaction are even more extreme than those of the deuterium-tritium fusion favored in the current ITER fusion reactor experiment. Igniting the proton-boron reaction is more difficult by comparison, and scientists are still searching for viable ways to do so. Schützhold’s team now points to one possibility: “According to our calculations, a sufficiently fast and strong pulsed electric field can significantly enhance not only deuterium-tritium fusion but also the proton-boron reaction.”

However, generating such fields is very difficult. “In principle, we can think of it as being like a thunderstorm, where the energy stored in huge cloud formations is discharged in the form of a lightning strike in a very short time and in a very confined space. Facilities are being built or planned around the world that are intended to concentrate ever higher energies into ever shorter periods of time and ever smaller spatial areas,” says Schützhold. Unfortunately, the facilities available today are not yet quite capable of generating such fast and powerful “artificial lightning.”

But there is a possible way out: The electric field of an alpha particle flying fast and, above all, close to the proton can act like such a pulsed electric field and strike so strongly that the proton can tunnel through the potential barrier of boron-11 and trigger the fusion reaction. Alpha particles with the necessary pulse energy are actually generated in the proton-boron reaction, but they can also be injected from outside.




Continue Reading

Biotechnology Chemicals News Pharmaceuticals Processing Technologies

Therapeutics and bioinsecticides: production by spider venom



The venom of a single spider can contain up to 3000 components. The components, mostly peptides, can be used to develop promising active ingredient candidates for the treatment of diseases. Spider venom can also be used in pest control – as a biological pesticide. A team of researchers from the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Justus Liebig University Giessen is focusing on native spiders and their venom mix, which have received little attention to date. The research results on the biology of the toxins – especially on the venom of the wasp spider – have been published in scientific journals.

Spiders make many people uncomfortable, and some are even afraid of the eight-legged creatures. At the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Giessen, however, they are welcome. Here, biochemist Dr. Tim Lüddecke and his team are conducting research on spider toxins.

“Spider toxins are a largely untapped resource, this is partly due to the sheer diversity – some 50,000 species are known. There is a lot of potential in spider venom for medicine, for example in researching disease mechanisms.”

– Dr. Tim Lüddecke, head of the new “Animal Venomics” research group

For example, it is possible to study in the laboratory how individual toxins act on pain receptors of nerve cells. The venom cocktail of the Australian funnel web spider is particularly promising. It is assumed that it can be used to treat neuronal damage after strokes and to make hearts for organ transplants last longer. Other drug candidates are of interest for use as antibiotics or painkillers. “This is a very young field of research. The substances have been discovered and described, but they are not yet in the preclinical stage,” Lüddecke said. Pesticide research is a different story. Spiders stun insects with their venom and then eat them. Because the toxins are very effective against insects, they provide a good basis for biopesticides; they are suitable for crop pest control.

Research to date has focused on the toxins of the very large or potentially dangerous species that live in the tropics. The native, small and harmless spiders have not been in focus. “Most spiders in Central Europe are no more than two centimeters in size, and their venom levels were not sufficient for experiments. But now we have precise analytical methods to study even the small amounts of the previously neglected majority of spiders,” explains Lüddecke. The working group at the Giessen Bioresources branch of the Fraunhofer IME is devoting itself to these species as part of a research project. In the process, they are collaborating with research teams from the Justus Liebig University in Giessen, among others. The work is funded by the LOEWE Center for Translational Biodiversity Genomics (LOEWE-TBG) in Frankfurt am Main.

The scientists are paying particular attention to the wasp spider (Argiope bruennichi), which owes its name to its striking wasp-like coloration. They have succeeded in decoding its venom, identifying numerous novel biomolecules. The research findings were published in the journal Biomolecules.

New biomolecules from wasp spider venom

Spider venoms are highly complex, they can contain up to a maximum of 3000 components. The venom of the wasp spider, on the other hand, contains only about 53 biomolecules. It is heavily dominated by high-molecular-weight components, including so-called CAP proteins and other enzymes. As in other spider venoms, knottins are present – but these make up only a small part of the total mixture.

Knottins represent a group of neurotoxic peptides that are robust to chemical, enzymatic, and thermal degradation due to their nodal structure. One could therefore administer these molecules orally as a component of drugs without digesting them in the gastrointestinal tract. They can therefore exert their effects very well, which is why they offer great potential for medicine. In addition, knottins bind specifically to ion channels. “The more specifically a molecule docks onto its target molecule, attacking only a single type of ion channel, the fewer side effects it triggers,” explains Lüddecke. Moreover, even in small amounts, the knottins affect the activity of the ion channels, i.e., they are effective at low concentrations. As a result, derived drugs can be administered in low doses. The combination of these properties is what makes spider venoms so interesting for science.

The project partners also discovered molecules in the wasp spider’s venom that are similar in structure to neuropeptides, which are responsible for transporting information between nerve cells. “We have found novel families of neuropeptides that we have not previously seen in other spiders. We suspect that the wasp spider uses them to attack the nervous system of insects. It has been known for some time that neuropeptides in the animal kingdom are frequently converted into toxins in the course of evolution,” says the researcher.

Replicating toxins in the lab

Since the toxin yield is low in small spiders, the researchers extract the toxin glands and sequence the mRNA from them. Based on the gene structure, the toxins can be decoded. The venom profile of the wasp spider is now available in its entirety, and the next step is to produce the relevant components. For this, the gene sequence is incorporated into a bacterial cell using biotechnology, which then produces the toxin. “We are building quasi genetically modified bacteria that produce the toxin on a large scale.” Lüddecke and his team have been able to mass produce the main component of the wasp spider toxin, the CAP protein. The first functional studies will start soon.

Venom of male and female spiders differs

In another review paper, the biochemist, in cooperation with colleagues at the Justus Liebig University of Giessen and researchers at the Australian University of the Sunshine Coast, was able to deduce that spider venoms are very dynamic and that many influences shape their composition and functionality. “The dynamics of spider venom have been completely underestimated. The biochemical repertoire is critically influenced by life stage, habitat, and especially sex. Even the venom cocktail of juveniles and adults is not necessarily identical. It is rather the interaction of the many components that makes spider venom so effective than the effect of a single toxin. Through their interactions, the components increase their effectiveness,” the researcher sums up.

Continue Reading

Chemicals Measurement, Instrumentation, Control & Automation Pumps & Compressors

Safe solution to process a wide range of products
Treatment of products with high vacuum



A very important Germany fine-chemical company has chosen a 3000 liters Bi-Evolution Dryer (model RB 3000) fully equipped with vacuum pump, condensing unit, H/C unit and control-system by Italvacuum. The Bi-Evolution Dryer is Italvacuum’s double cone rotary vacuum dryer that provides high level performances to fulfill the production needs of modern-day firms in the chemical, fine chemical and pharmaceutical industry, amongst many others. It keeps up with today’s increasingly stringent safety regulations, such as Atex, FDA, Asme, cGMP, Ehedg, CE, Ex.



Italvacuum can provide turnkey installation; the company offers every necessary component for a flawless production process, from vacuum pumps and H/C units together with the control-system. Furthermore the company is also able to serve and support costumers on an international scale in different stages of projects: before the choice thanks to high skilled engineer and the possibility of pilot test in house or off site and during the phase of installation/ after sales thanks to highly specialized staff that can provide scheduled preventive maintenance or prompt technical assistance.


For more information about Italvacuum:

Continue Reading